These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22030866)

  • 1. Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology.
    Lemaire D; Barbosa T; Rihet P
    Braz J Med Biol Res; 2012 May; 45(5):376-85. PubMed ID: 22030866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines based on structure-based design provide protection against infectious diseases.
    Thomas S; Luxon BA
    Expert Rev Vaccines; 2013 Nov; 12(11):1301-11. PubMed ID: 24090172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing field of vaccine development in the genomics era.
    Brusic V; August JT
    Pharmacogenomics; 2004 Sep; 5(6):597-600. PubMed ID: 15335280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious Disease and the Diversification of the Human Genome.
    Brinkworth JF
    Hum Biol; 2017 Jan; 89(1):47-65. PubMed ID: 29285966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine immunogenetics: bedside to bench to population.
    Poland GA; Ovsyannikova IG; Jacobson RM
    Vaccine; 2008 Nov; 26(49):6183-8. PubMed ID: 18598732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Challenges in Vaccinology.
    Kennedy RB; Ovsyannikova IG; Palese P; Poland GA
    Front Immunol; 2020; 11():1181. PubMed ID: 32670279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing vaccine responses using host genomic and transcriptomic analysis.
    O'Connor D; Pollard AJ
    Clin Infect Dis; 2013 Sep; 57(6):860-9. PubMed ID: 23728145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in vaccine response in normal populations.
    Ovsyannikova IG; Jacobson RM; Poland GA
    Pharmacogenomics; 2004 Jun; 5(4):417-27. PubMed ID: 15165177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of Novel Materials and Advanced Genomic Technologies into New Vaccine Design.
    Liao W; Zhang TT; Gao L; Lee SS; Xu J; Zhang H; Yang Z; Liu Z; Li W
    Curr Top Med Chem; 2017; 17(20):2286-2301. PubMed ID: 28240182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
    Poland GA; Ovsyannikova IG; Jacobson RM; Smith DI
    Clin Pharmacol Ther; 2007 Dec; 82(6):653-64. PubMed ID: 17971814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genomics and genetics of human infectious disease susceptibility.
    Hill AV
    Annu Rev Genomics Hum Genet; 2001; 2():373-400. PubMed ID: 11701655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinology in the genome era.
    Rinaudo CD; Telford JL; Rappuoli R; Seib KL
    J Clin Invest; 2009 Sep; 119(9):2515-25. PubMed ID: 19729849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary determinants of genetic variation in susceptibility to infectious diseases in humans.
    Baker C; Antonovics J
    PLoS One; 2012; 7(1):e29089. PubMed ID: 22242158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in research of influence of gene polymorphisms on immune response].
    Cao JQ; Li JX; Wang YY; Zhu FC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1515-1518. PubMed ID: 30462964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic detection of positive selection in the human-pathogen interactome and lasting effects on infectious disease susceptibility.
    Corona E; Wang L; Ko D; Patel CJ
    PLoS One; 2018; 13(5):e0196676. PubMed ID: 29799843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of genomics in microbial vaccine development.
    Bambini S; Rappuoli R
    Drug Discov Today; 2009 Mar; 14(5-6):252-60. PubMed ID: 19150507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology in vaccine design.
    Six A; Bellier B; Thomas-Vaslin V; Klatzmann D
    Microb Biotechnol; 2012 Mar; 5(2):295-304. PubMed ID: 22189033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches and omics tools for mining of vaccine candidates against vector-borne diseases.
    Kuleš J; Horvatić A; Guillemin N; Galan A; Mrljak V; Bhide M
    Mol Biosyst; 2016 Aug; 12(9):2680-94. PubMed ID: 27384976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles in Immunology for the Design and Development of Vaccines.
    Meyer CU; Zepp F
    Methods Mol Biol; 2022; 2410():27-56. PubMed ID: 34914041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.